Amphastar Pharmaceuticals (AMPH) EBT Margin (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly EBT Margin of 5.87% for Q1 2026, down 1223.0% year-over-year from 0.52% in Q1 2025, and down 66.31% quarter-over-quarter from 17.43% in Q4 2025.
Amphastar Pharmaceuticals (AMPH) EBT Margin (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' EBT Margin history runs 14 years deep, the most recent figure standing at 5.87% for Q1 2026.
- In Q1 2026, EBT Margin fell 1223.0% year-over-year to 5.87%; the TTM figure through Mar 2026 stood at 14.27% (down 937.0% YoY), while the FY2025 annual figure was 17.17%, down 875.0% from the prior year.
- EBT Margin for Q1 2026 stood at 5.87%, down from 17.43% in the prior quarter.
- The five-year high for EBT Margin was 35.25% in Q3 2023, with the low at 78.93% in Q4 2023.
- The 5-year median for EBT Margin is 22.55% (2025), against an average of 16.12%.
- The sharpest annual moves came in 2023 and 2024: EBT Margin sank 10949 bps in 2023, then soared 10250 bps in 2024.
- Amphastar Pharmaceuticals' EBT Margin stood at 30.56% in 2022, then tumbled by 358 bps to 78.93% in 2023, then jumped by 130 bps to 23.57% in 2024, then retreated by 26 bps to 17.43% in 2025, then sank by 66 bps to 5.87% in 2026.
- Business Quant data shows AMPH's EBT Margin at 5.87% in Q1 2026, 17.43% in Q4 2025, and 11.21% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 933.76 Mn | 643.64 Mn | 93.47 Mn | 20.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.96% |
| Mar 31, 2026 | 5.87% |
| Dec 31, 2025 | 17.43% |
| Sep 30, 2025 | 11.21% |
| Jun 30, 2025 | 22.55% |
| Mar 31, 2025 | 18.10% |
| Dec 31, 2024 | 23.57% |
| Sep 30, 2024 | 24.94% |
| Jun 30, 2024 | 27.55% |
| Mar 31, 2024 | 27.86% |
| Dec 31, 2023 | -78.93% |
| Sep 30, 2023 | 35.25% |
| Jun 30, 2023 | 22.52% |
| Mar 31, 2023 | 23.97% |
| Dec 31, 2022 | 30.56% |
| Sep 30, 2022 | 18.81% |
| Jun 30, 2022 | 18.75% |
| Mar 31, 2022 | 24.12% |
| Dec 31, 2021 | 22.47% |
| Sep 30, 2021 | 33.55% |